6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Rheumatoid Arthritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bulleri, M; Di Munno, O; Giordani, R; Mazzantini, M; Metelli, MR | 1 |
Benucci, M; Dolenti, S; Manfredi, M; Saviola, G | 1 |
2 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Rheumatoid Arthritis
Article | Year |
---|---|
Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers.
Topics: Aged; Amino Acids; Arthritis, Rheumatoid; Biomarkers; Blood Sedimentation; Bone Resorption; C-Reactive Protein; Collagen; Collagen Type I; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Male; Middle Aged; Peptides | 2002 |
[Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
Topics: Aged; Arthritis, Rheumatoid; Bone Resorption; Calcium; Data Interpretation, Statistical; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Middle Aged; Osteoporosis; Polymyalgia Rheumatica; Sjogren's Syndrome; Time Factors; Treatment Outcome; Vitamin D | 2006 |